Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 1, 1996American Journal of Respiratory and Critical Care Medicine

Efficacy and Safety of Rifabutin in the Treatment of Patients With Newly Diagnosed Pulmonary Tuberculosis

View Full Paper
Ask AI
Bookmark
Share

Authors

MMM M McGregorPOP OlliaroMalaria ConsortiumLWLouise WolmaransUniversity of Auckland

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

McGregor et al. (1996) studied this question.

synapsesocial.com/papers/6a8297791d8eddfbf50f672bhttps://doi.org/10.1164/ajrccm.154.5.8912765
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Tuberculosis in the 1990s1993 · 202 citations
  2. 2Rifabutin (Ansamycin LM 427): A New Rifamycin-S Derivative for the Treatment of Mycobacterial Diseases1987 · 116 citations
  3. 3The New Tuberculosis1992 · 385 citations
  4. 4Autoinduction of rifabutin metabolism in man1990 · 42 citations
  5. 5Rifabutin treatment for tuberculosis patients with liver function abnormalities1992 · 16 citations